InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
1
T+90 hit rate
50%
T+90 mean return
+0.9%
Across 10 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by PAPADOPOULOS STELIOS, Director. Officer active across 3 companies, notably Exelixis, INC.. Aggregated, 21 filings have been recorded. Breakdown: 0 buy · 1 sell. Total volume traded: €1.5m. Activity tracked since 11 May 2021. The latest transaction was filed on 27 May 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Declarations21 total
8,367 shares0Common StockSEC:0000939767-26-000083:0
9,812 shares0Common StockSEC:0000939767-25-000088:0
20,634 shares@ US$19.7714.9% of flowCommon StockSEC:0000939767-25-000080:0
62,500 shares0Common StockSEC:0000950170-25-061119:0
18,838 shares0Common StockSEC:0000939767-24-000102:0
11,686 shares@ US$19.578.6% of flowCommon StockSEC:0000939767-24-000075:0
250,000 shares@ US$1.6018.6% of flowCommon StockSEC:0000950170-24-032213:0
20,718 shares0Common StockSEC:0000939767-23-000056:0
222,198 shares@ US$0.90019.2% of flowCommon StockSEC:0001209191-23-024329:0
2,255 shares0Common StockSEC:0001127602-22-017806:0
19,575 shares0Common StockSEC:0000939767-22-000079:0
84,515 shares@ US$19.560.013% mcap77.9% of flowCommon StockSEC:0000939767-22-000031:0
2,222,222 shares@ US$0.36100.0% of flowCommon StockSEC:0001209191-21-067264
2,222,222 shares@ US$0.3650.0% of flowCommon StockSEC:0001209191-21-067264:0
1,275 shares0Common StockSEC:0001127602-21-021336:0
1,275 shares0Common StockSEC:0001127602-21-021336
16,424 shares0Common StockSEC:0000939767-21-000063
16,424 shares0Common StockSEC:0000939767-21-000063:0
40,000 shares@ US$6.300.0018% mcap11.1% of flowCommon StockSEC:0000939767-21-000049:0
40,000 shares@ US$6.3011.1% of flowCommon StockSEC:0000939767-21-000049
15,071 sharesCommon StockSEC:0000939767-16-000129:0
21 of 21 declarations
About PAPADOPOULOS STELIOS
Stelios Papadopoulos serves as a Board Member at Exelixis, Inc., Biogen Inc., and Regulus Therapeutics Inc. With extensive experience in the biopharmaceutical sector, he contributes to the governance and strategy of these companies. His role is crucial in guiding strategic decisions and promoting innovation in the development of new treatments.
